Cleared Traditional

BD PureHub Disinfecting Cap

K193190 · Becton, Dickinson and Company · General Hospital
Nov 2020
Decision
356d
Days
Class 2
Risk

About This 510(k) Submission

K193190 is an FDA 510(k) clearance for the BD PureHub Disinfecting Cap, a Cap, Device Disinfectant (Class II — Special Controls, product code QBP), submitted by Becton, Dickinson and Company (Franklin Lakes, US). The FDA issued a Cleared decision on November 9, 2020, 356 days after receiving the submission on November 19, 2019. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5440.

Submission Details

510(k) Number K193190 FDA.gov
FDA Decision Cleared SESE
Date Received November 19, 2019
Decision Date November 09, 2020
Days to Decision 356 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code QBP — Cap, Device Disinfectant
Device Class Class II — Special Controls
CFR Regulation 21 CFR 880.5440
Definition Disinfect Needleless Access Valves And May Act As A Physical Barrier To Contamination If Not Removed For A Set Period Of Time

More from Becton, Dickinson and Company

View all
BD Vacutainer? Plasma Separator Tubes (PST?), BD Vacutainer? Sodium Heparin Blood Collection Tubes
K252040 · JKA · Mar 2026
0.9 % Sodium Chloride Injection, USP, BD PosiFlush? SP Syringe
K250884 · NGT · Dec 2025
BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR System, and Enteric Bacterial Panel Diluent for BD COR System
K250358 · PCI · Oct 2025
BD PhaSeal? Optima Connecting Set (C83-O); BD PhaSeal? Optima Spike Set (C180-O)
K250059 · ONB · Sep 2025
BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 ?g/mL)
K251713 · LON · Aug 2025